Impact BioMedical Inc. (IBO) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -464K | 99K | -613K | -694K | -981 | -1.81M | -1.74M | -896K | -482K | -433K | -911 | -971 |
| Operating CF Margin % | -6628.57% | 1414.29% | -3405.56% | -9914.29% | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -47198.67% | 105.48% | 64.69% | - | - | - | - | -92176% | -179.99% | 9.9% | 99.8% | 99.94% |
| Net Income | -2.29M | 15.82M | -1.47M | -14.35M | -1.82K | -38.98M | 5.74M | -882K | -998K | -1.26M | -1.58K | -1.46K |
| Depreciation & Amortization | 285K | 568.66K | 288K | 288K | 407 | 401.23K | 379.6K | 279K | 280K | 280K | 380 | 371 |
| Stock-Based Compensation | 0 | 12K | 1K | -27K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | -2.58M | 0 | 0 | 0 | 47.46K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 1.44M | -14.26M | 530K | 13.39M | 278 | 37.32M | -7.66M | -230K | 230K | 0 | 217 | 128 |
| Working Capital Changes | 95K | 541K | 42K | 6K | 157 | -592.49K | -187.77K | -63K | 6K | 548K | 69 | -11 |
| Change in Receivables | 5K | 10K | -15K | 0 | 0 | 0 | 172.91K | 0 | 0 | 0 | 128 | -124 |
| Change in Inventory | 0 | 3K | 1K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 27K | 607K | 22K | -61K | 0 | -870.04K | 20.26K | -37K | 191K | 356K | 0 | 0 |
| Cash from Investing | -1K | 1K | 1K | 0 | 0 | 0 | 1.35K | 1K | 0 | 1K | 0 | -15 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -16 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -1K | 1K | 1K | 0 | 0 | 0 | 1.35K | 1K | 0 | 1K | 0 | 0 |
| Cash from Financing | 482K | -109K | 0 | 0 | 0 | 844.16K | 5.34M | 895K | 483K | 232K | 1.18K | 988 |
| Debt Issued (Net) | 482K | -109K | 0 | 0 | 0 | 844.16K | 302.6K | 895K | 483K | 232K | 0 | 0 |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 5.03M | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.18K | 988 |
| Net Change in Cash | 17K | -9K | -612K | -694K | -977 | -962.08K | 3.6M | 0 | 1K | -200K | 269 | 0 |
| Free Cash Flow | -464K | 99K | -613K | -694K | -981 | -1.81M | -1.74M | -896K | -482K | -433K | -912 | -986 |
| FCF Margin % | -6628.57% | 1414.29% | -3405.56% | -9914.29% | - | - | - | - | - | - | - | - |
| FCF Growth % | -47198.67% | 105.48% | 64.69% | - | - | - | - | -90772.21% | -124.3% | 37.37% | 99.85% | 99.94% |
| FCF per Share | -0.00 | 0.00 | -0.05 | -0.06 | -0.00 | -0.16 | -0.02 | -0.08 | -0.04 | -0.01 | -0.01 | -0.01 |
| FCF Conversion (FCF/Net Income) | 0.20x | 0.02x | 0.42x | 0.05x | 0.00x | 0.07x | -0.41x | 1.01x | 0.50x | 0.35x | 0.00x | 0.00x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |